Akerna Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

Equity (Tables)

9 Months Ended

Sep. 30, 2022

Schedule of share based compensation stock warrant activity

	Exercise Price		Expiration Date	Balance as of December 31, 2021		Issued		Exercised			Expired		Balance as of September 30, 2022
2019 Public Warrants (1)	$	230.00	6/19/2024		5,813,800		—		—			—		5,813,800
2022 Unit Offering
Pre-funded Warrants (2)	$	0.002	6/29/2027		—		14,095,400		(14,095,400	)		—		-
Common Warrants (3)	$	4.60	6/29/2027		—		43,478,261		—			—		43,478,261
Underwriter Warrants (3)	$	4.60	6/29/2027		—		2,173,913		—			—		2,173,913
					5,813,800		59,747,574		(14,095,400	)		—		51,465,974

(1) The 2019 Public Warrants are exercisable for 290,690 shares of Common Stock at $230.00 per share or a ratio of 20 warrants for one share of Common Stock.

(2) A total of 14,095,400 Pre-funded Warrants were issued and exercised in exchange for 704,770 shares of Common Stock.

(3) The Common Warrants and Underwriter Warrants are exercisable for a combined amount of 2,282,609 shares of Common Stock at $4.60 per share or a ratio of 20 warrants for one share of Common Stock.